Mt Sinai
Mt Sinai
New York, New York, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, refractory hematologic cancer | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT03328078 | |
| Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Active, not recruiting | Not applicable | 2024-12-06 | NCT04301518 | |
| PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life | Female Urogenital Diseases and Pregnancy Complications, Nutritional and Metabolic Diseases, Pregnancy in Diabetics, Urogenital Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, pregnancy disorder, type 1 diabetes mellitus | Recruiting | Not stated | 2023-11-21 | NCT06141434 |